key: cord-0837349-eqcjnsl3
authors: Su, Mack Y.; Smith, Gideon P.; Das, Shinjita
title: Trends in teledermatology use during clinic reopening after COVID-19 closures
date: 2020-12-11
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.12.019
sha: d82ea3a7bc04dbb6ad8eb1473bdbde474338ef7c
doc_id: 837349
cord_uid: eqcjnsl3

nan

To the Editor: Teledermatology has provided vital dermatology care as the COVID-19 pandemic forced ambulatory clinics to cease or limit inperson visits. 1 Despite rapid large-scale implementation of teledermatology, the optimal use of telemedicine for specific dermatologic conditions remains unclear. 2 As clinics reopen, telemedicine use, although decreased, continues to account for a substantial proportion of overall visits. 3 This period of reopening provides an opportunity to monitor teledermatology trends when virtual and in-person visits are both available and have reimbursement parity. These findings can help guide future decisions regarding which types of dermatologic conditions may be preferentially addressed via teledermatology.

We extracted all adult teledermatology encounters billed within our department from May through July 2020. This includes a period when ambulatory dermatology clinics were closed to all nonurgent inperson visits and a phased reopening of clinics beginning May 26, 2020. For each month, teledermatology visits were tabulated and divided into categories based on the primary billing diagnosis. Baseline characteristics differed for patients completing teledermatology visits across May, June, and July (Table I) . From May to July, the proportion of teledermatology visits completed by younger (ages 18-44 years), Asian, and privately insured patients increased, whereas those completed by older (ages $65 years), White, and Medicare patients decreased. The total number of teledermatology visits decreased from 1650 in May to 1514 in June to 818 in July (Table II) . 4 Several trends in teledermatology use for certain categories of diagnoses emerged. As the option for in-person evaluation and management became available, teledermatology visits for skin lesions and named cutaneous malignancies decreased. Interestingly, teledermatology visits for benign skin lesions did not decrease significantly, indicating that teledermatology may be acceptable for initial evaluation of low-risk lesions (as perceived by the patient) and reassurance for benign lesions. As clinics reopened, the proportion of teledermatology visits for common dermatoses (acne, rosacea, psoriasis, atopic dermatitis, and eczema) increased, while visits for unspecified or less common rashes did not change significantly. This suggests patients and/or dermatologists may feel comfortable managing common dermatoses via teledermatology even when inperson evaluation is an option.

Our observations at a single urban academic institution may not generalize across all ambulatory settings, but we think monitoring telemedicine trends will help dermatology practice models to evolve in the era of telemedicine. While underlying differences in patient characteristics may affect visit diagnoses, our survey can serve as a starting point for telemedicine optimization. Studies will be needed to distinguish whether case trends are driven by institutional constraints, dermatologists, or patients. The United States federal government has signaled sustained enthusiasm for telehealth by adding new permanent telemedicine codes in August 2020. 5 Consequently, dermatology practices will need to optimize teledermatology use to balance in-person clinic volume limitations and access constraints. Our initial analyses suggest that from a practice perspective, common dermatoses have a place in core teledermatology offerings moving forward. Continued monitoring of teledermatology trends will enhance our understanding of best practices.

Mack Y. Su, PhD, Gideon P. Smith, MD, PhD, MPH, and Shinjita Das, MD 

Teledermatology in the era of COVID-19: experience of an academic department of dermatology

Fighting COVID-19: early teledermatology lessons learned

The impact of the COVID-19 pandemic on outpatient visits: changing patterns of care in the newest COVID-19 hot spots. To the Point (blog)

DescTools: Tools for descriptive statistics

Department of Health and Human Services. 42 CFR Parts 410, 414, 415, 423, 424, and 425

Trends in teledermatology use Category May

%) July, No. (%) P value* Adjusted P value